-
Hugo Beck Sets the Course for the Future Under Third-Generation Family Leadership - July 7, 2025
-
VALUE-ADDED SERVICES INCREASINGLY IMPORTANT SAYS BCMPA AHEAD OF NATIONAL LOGISTICS DAY 2025 - July 7, 2025
-
AVOID AI CAMERA OPPOSITION WITH MOBILE PHONE BLOCKING ALTERNATIVE - June 30, 2025
-
iplicit and Cin7 announce strategic partnership to address ‘neglected’ wholesale and distribution midmarket - June 30, 2025
-
Bonx raises $8.6 million to champion European manufacturing with market-leading AI ERP - June 30, 2025
-
Mileway secures major lease agreement with Eurosonic Group Ltd in Manchester - June 27, 2025
-
MARLIN INDUSTRIES DRIVES DOWN INSURANCE CLAIMS AND TACKLES FLEET RISK WITH SURECAM VIDEO TELEMATICS - June 26, 2025
-
ARROWXL SECURES FIFTH CONSECUTIVE GOLD ROSPA AWARD - June 24, 2025
-
PROLOG FULFILMENT APPOINTS NEW HEAD OF HUMAN RESOURCES - June 24, 2025
-
Woodland Group Launches 2024 Sustainability Report, Showcasing Measurable Carbon Cuts and Industry Progress - June 20, 2025
Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper
The vital role that temperature-controlled packaging plays in transporting pharmaceuticals around the world has been highlighted in a new white paper from Tower Cold Chain, with the aim of helping stakeholders find the right solution for their needs.
Compounded by the demands of the COVID-19 pandemic, the white paper provides practical advice on the various options available, with insight delivered by seven leading industry experts from across the supply chain. These include senior decision makers from Johnson & Johnson, DHL and LOT Polish Airlines, who deliver an unbiased guide that is ideal for specifiers in pharmaceuticals, 3PL and air freight looking to make informed choices.
Free to download from the Tower website, the white paper – titled ‘Passive v Active in a globally disrupted age’ – collates the key findings of a 90-minute webinar organised by Tower in late 2021. Amongst the topics covered are the rapid changes affecting the industry; the new challenges that are arising in delivering vaccines to remote areas; and the considerations that must be made in selecting the optimum container type for the task.
At the heart of the publication is an assessment of the relative merits of Active, Passive and Hybrid temperature-controlled packaging solutions with detailed insight on their use across the global pharmaceutical supply chain.
In an unbiased review of the technologies the white paper identifies a place for all types of temperature-controlled solutions within the market.
“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” explains Kevin Doran, Global Head of Supply Chain at Tower Cold Chain.
“When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan. We felt it was vital that decision makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology.
“We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”
The white paper can be downloaded here.